Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Scientific Reports|June 15, 2016
Pharmacogenetics-Guided Phase I Study of Capecitabine on an Intermittent Schedule in Patients with Advanced or Metastatic Solid TumoursRoss Andrew Soo, Nicholas Syn, Soo-Chin Lee, et al.
Singapore Medical Journal|September 7, 2023
Presenting characteristics, histological subtypes and outcomes of adult central nervous system tumours: retrospective review of a surgical cohortMervyn Jun Rui Lim, Yilong Zheng, Sean Wai-Onn Eng, et al.
Cancer Letters|July 28, 2016
A novel combinatorial strategy using Seliciclib(®) and Belinostat(®) for eradication of non-small cell lung cancer via apoptosis induction and BID activationPei-Shi Ong, Lingzhi Wang, Deborah Miao-Hui Chia, et al.
Oncotarget|February 4, 2017
Combined use of irinotecan with histone deacetylase inhibitor belinostat could cause severe toxicity by inhibiting SN-38 glucuronidation via UGT1A1Lingzhi Wang, Chong En Linus Chan, Andrea Li-Ann Wong, et al.
Cancer|April 2, 2019
Biopharmacological considerations for accelerating drug development of deguelin, a rotenoid with potent chemotherapeutic and chemopreventive potentialRahel Sarah Varughese, Walter Sze-Tung Lam, Ahmad Abdurrahman Bin Hanifah Marican, et al.
BMJ Open|October 25, 2023
CURATE.AI COR-Tx platform as a digital therapy and digital diagnostic for cognitive function in patients with brain tumour postradiotherapy treatment: protocol for a prospective mixed-methods feasibility clinical trialAlexandria Remus, Xavier Tadeo, Grady Ng Shi Kai, et al.
Singapore Medical Journal|February 11, 2025
Knowledge, attitudes and perceptions of advance care planning among specialist healthcare professionals in neurology, neuro-oncology and surgeryZheting Zhang, Jing Ni Ng, Felicia Jin Yee Sie, et al.
Cancer Letters|January 7, 2018
Pan-HDAC inhibition by panobinostat mediates chemosensitization to carboplatin in non-small cell lung cancer via attenuation of EGFR signalingLingzhi Wang, Nicholas Li-Xun Syn, Vinod Vijay Subhash, et al.
Plos One|February 6, 2013
Glucuronidation by UGT1A1 is the dominant pathway of the metabolic disposition of belinostat in liver cancer patientsLing-Zhi Wang, Jacqueline Ramírez, Winnie Yeo, et al.
BMC Medicine|July 11, 2018
Genotype-guided versus traditional clinical dosing of warfarin in patients of Asian ancestry: a randomized controlled trialNicholas L Syn, Andrea Li-Ann Wong, Soo-Chin Lee, et al.
Pageof 5